Response to hepatitis B virus vaccination in haemodialysis patients with and without hepatitis C infection

Eastern Mediterranean Health Journal

Volumn 14, Issue 4, 2008, Pages 798-803

  Sorkhi, Hadi ^a   Roushan, M R H ^a   Al Hashemi, G H ^b   Dooki, M R E ^a   Bai, S ^a  

^a BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B ANTIGEN; HEPATITIS B CORE ANTIBODY; RECOMBINANT HEPATITIS B VACCINE;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HEMODIALYSIS; HEPATITIS B; HEPATITIS C; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; TREATMENT DURATION; VACCINATION;

ADULT; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNIZATION SCHEDULE; IRAN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; VACCINATION;

EID: 53749095739     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Tandon BN, Acharya SK, Tandon A. Epidemiology of hepatitis B virus infection in India. Gut, 1996, 2:s56-9.
2. Purcell RH. The discovery of the hepatitis viruses. Gasteroentology, 1993, 104:55-63.
3. Kohler H. Hepatitis B immunization in dialysis patients - is it worthwhile? Nephrology, dialysis, transplantation, 1994, 9:1719-20.
4. Rapicetta M. Hepatitis B vaccination in dialysis centers: advantages and limits. Nephron, 1992, 61:284-6.
5. Gimdt M, Pietsch M, Kohler H. Tetanus immunization and its association to hepatitis B vaccination in patients with chronic renal failure. American journal of kidney diseases, 1995, 26(3):454-60.
6. Miller ER, Alter MJ, Tokars JI. Protective effect of hepatitis B vaccine in chronic haemodialysis patients. American journal of kidney diseases, 1999, 33(2):356-60.
7. Drachman R et al. Vaccination against hepatitis B in children and adolescent patients on dialysis. Nephrology, dialysis, transplantation, 1989, 4:372-4.
8. Pol S et al. Genetic basis to hepatitis B vaccine in hemodialyzed patients. Journal of hepatology, 1990, 11:385-7.
9. Caillat-Zucman S et al. Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen. Kidney international, 1998, 53:1626-30.
10. Lewis-Ximenez LL et al. Serological and vaccination profile of hemodialysis patients during an outbreak of hepatitis B virus infection. Nephron, 2001, 87:19-26.
11. Dukes CS etal. Hepatitis B vaccination and booster in predialysis patients: a 4-year analysis. Vaccine, 1993, 11(12):1229-32.
12. Kohler H et al. Active hepatitis B vaccination of dialysis patients and medical staff. Kidney international, 1984, 25:124-8.
13. Mitwalli A. Responsiveness to hepatitis B vaccine in immunocompromised patients by doubling the dose scheduling. Nephron, 1996, 73:417-20.
14. Vlassopoulos D et al. Factors involved in low response to HBV vaccine in health and end-stage renal failure. Nephrology, dialysis, transplantation, 1998, 13:A191.
15. Descamps-Latscha B, Chatenoud L. T cells and B cells in chronic renal failure. Seminars in nephrology, 1996,16(3):183-91.
16. Rahman F et al. Cellular and humoral responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen. Hepatology, 2000, 31:521-7.
17. Carletti P et al. HBV infection in haemodialysis patients: monitoring and prevention. Nephron, 1992, 61:269-70.
18. Fabrizi F et al. Intradermal versus intramuscularly hepatitis B vaccination in nonresponding chronic dialysis patients: a prospective randomized study with cost-effectiveness evaluation. Nephrology, dialysis, transplantation, 1997, 12:1204-11.
19. Navarro JF et al. Hepatitis C virus infection decreases the effective antibody response to hepatitis B vaccine in haemodialysis patients. Clinical nephrology, 1994, 41(22):113-6.
20. Peces R et al. Prospective analysis of the factors influencing the antibody response to hepatitis B vaccine in hemodialysis patients. American journal of kidney diseases, 1997, 29(2):239-45.
21. Cheng CH et al. Hepatitis B Vaccine in hemodialysis patients with hepatitis C viral infection. Vaccine, 1997, 15(12-13): 1353-7.
22. Navarro JF et al. Antibody level after hepatitis B vaccination in haemodialysis patients: influence of hepatitis C virus infection. American journal of nephrology, 1996, 16(2):95-7.
23. 2002 annual data report (ADR)/Atlas. Bethesda, Maryland, United States Renal Data System, 2000 (NIH/NIDDK/DKUHD).
24. Bel'eed K et al. Vaccination against hepatitis B infection in patients with end stage renal disease. Postgraduate medical journal, 2002,78(923):538-40.
25. Fernandez E et al. Response to the hepatitis B virus vaccine in haemodiplysis patients: Influence of malnutrition and its importance as a risk factor for morbidity and mortality. Nephrolopy, dialysis, transplantation, 1996, 11(8):1559-63.
26. Sezer S et al. Factors influencing response to hepatitis B virus vaccination in hemodialysis patients. Transplantation proceedings, 2000, 32(3):607-8.
27. Jadoul M, Goubau P. Is anti-hepatitis B virus (HBV) immunization successful in elderly hemodialysis (HD) patients? Clinical nephrology, 2002, 58(4):301-4.
28. Chin Al. Hepatitis B virus vaccine response in hemodialysis: baseline patient characteristics. Kidney international, 2003, 7(4):296-303.
29. Vlassopoulos D et al. Complete success of intradermal vaccination against hepatitis B in advanced chronic renal failure and hemodialysis patients. Renal failure, 1997, 19(3):455-60.